GENTAmicin-collagen sponge reduces sternal wound complications after heart surgery

ISRCTN ISRCTN27652441
DOI https://doi.org/10.1186/ISRCTN27652441
Protocol serial number N/A
Sponsor University Hospital of Würzburg (Germany)
Funder Resorba Wound Care (Wundversorgung) GmbH & Co. KG (Germany)
Submission date
19/02/2011
Registration date
24/05/2011
Last edited
10/01/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Rainer Leyh
Scientific

University Hospital of Würzburg
Department for Thoracic, Cardiac and Thoracic Vascular Surgery
Oberdürrbacherstraße 6
Wuerzburg
97074
Germany

Email Leyh_r@klinik.uni-wuerzburg.de

Study information

Primary study designInterventional
Study designProspective double-blind randomised controlled study
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleGENTAmicin-collagen sponge reduces sternal wound complications after heart surgery: a prospective, double-blind, randomised controlled study
Study acronymGENTA
Study objectivesGentamicin-collagen sponge reduces sternal wound complications after heart surgery.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSternal wound infection
InterventionFrom June 2009 to June 2010, 723 out of 994 patients (72.7%) were enrolled (control group: n=369 versus intervention group: n=354). 723 consecutive cardiac surgery patients who underwent median sternotomy were assigned either to a control placebo-group (collagen sponge) or an intervention-group (gentamicin-collagen sponge). All patients received intevenous (i.v.) perioperative antibiotic prophylaxis.

All operations were performed on the heart and thoracic aorta via median sternotomy at the Clinic for Thoracic, Cardiac and Thoracic Vascular Surgery of Würzburg University Hospital.
Intervention typeDrug
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Gentamicin-collagen sponge
Primary outcome measure(s)Mediastinitis-occurrence of deep sternal wound (DSWI) infections within 30 days of index surgery (follow-up period)
Key secondary outcome measure(s)Occurrence of superficial wound infections (SSWI) requiring treatment, as well as further clinical parameters, including revision, bleeding volume, and need for transfusions during the follow-up period.
Completion date01/04/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexAll
Target sample size at registration800
Key inclusion criteria1. Male and female legally competent patient, aged 18 years or older
2. Cardiac surgery undergoing median sternotomy
3. Ability to provide written informed consent
4. No preoperative signs of thoracic inflammation
Key exclusion criteria1. Existing osteitis, immunosuppressive therapy, known hypersensitivity to aminoglycoside antibiotics
2. Concurrent immunological disease
3. Pregnancy or lactation
4. Participation in another clinical study
5. Inability to give consent to participate in the study
6. Refusal to participate in the study before and/or during the follow-up period
Date of first enrolment01/03/2011
Date of final enrolment01/04/2011

Locations

Countries of recruitment

  • Germany

Study participating centre

University Hospital of Würzburg
Wuerzburg
97074
Germany

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2012 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes